NCT05186948

Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 230 (actual)
• Sponsor: Innodem Neurosciences · Industry
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This study aims to develop and validate a sensitive and non-invasive eye-tracking software application.

Detailed description

This study will obtain participant responses to brief cognitive tests designed to evaluate several key functions known to be affected by the Cancer-related cognitive impairment (CRCI) and non-invasive eye movement measurements in response to visually presented stimuli during specifically designed eye-tracking tests. The study data will be used to develop machine learning algorithms and validate a software application intended to track the progressive component of the Cancer-related cognitive impairment (CRCI) and associated cognitive changes.

Conditions

• Cancer-related Cognitive Impairment

Interventions

Type	Name	Description
DEVICE	Eye-Tracking	Eye-tracking technology and algorithms used to successfully capture and track eye movements using an electronic tablet and the embedded camera of the device.

Timeline

• Start date: 2022-03-30
• Primary completion: 2025-01-20
• Completion: 2025-01-20
• First posted: 2022-01-11
• Last updated: 2026-04-06

Locations

1 site across 1 country: Canada